The noncytolytic CD8+ T lymphocyte response to HIV infection involves inhibition of virus replication around the time of early gene expression in the host cell. The precise mechanism(s) and the target(s) of suppression are unknown. To better understand this cellular immune response to HIV infection, we propose to perform detailed mapping of how HIV-1 gene expression is inhibited and identify the viral genetic elements responsible for this process.
The specific aims are: 1.) Identify the stage of the HIV life cycle that is inhibited 2.) Identify which viral genetic elements are involved in the sensitivity to this activity. Our kinetic analyses of HIV suppression in primary CD4+ T lymphocytes by CD8+ T lymphocytes revealed that inhibition occurred after reverse transcription, but before (or during) the time of early viral gene expression. Here, we will more precisely define this suppression by examining the different stages of the HIV life cycle during this time frame including nuclear transport, integration, transcription, elongation, viral mRNA expression, and viral protein expression. To dovetail with these approaches, the genetic elements of the virus that are responsible for sensitivity to CD8+ T cell mediated suppression will be examined by deriving suppression-resistant viruses in vitro. The contribution of mutations in the resistant viruses will be confirmed using chimeric constructs and site directed mutagenesis to fully map and characterize the viral regions involved in sensitivity. These studies will further our understanding of this potent means of virologic control and promote the development of this host cellular immune response in future therapeutic and vaccination strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI052779-03
Application #
6884622
Study Section
AIDS and Related Research 8 (AARR)
Program Officer
Voulgaropoulou, Frosso
Project Start
2003-04-01
Project End
2007-03-31
Budget Start
2005-04-01
Budget End
2007-03-31
Support Year
3
Fiscal Year
2005
Total Cost
$308,000
Indirect Cost
Name
Duke University
Department
Surgery
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Hancock, Gemma; Yang, Hongbing; Yorke, Elisabeth et al. (2015) Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses. PLoS Pathog 11:e1004658
Payne, Tamika L; Blackinton, Jeff; Frisbee, Alyse et al. (2014) Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. J Virol 88:9514-28
Freel, Stephanie A; Saunders, Kevin O; Tomaras, Georgia D (2011) CD8(+)T-cell-mediated control of HIV-1 and SIV infection. Immunol Res 49:135-46
Saunders, Kevin O; Ward-Caviness, Cavin; Schutte, Robert J et al. (2011) Secretion of MIP-1? and MIP-1? by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage. Cell Immunol 266:154-64
Shen, Xiaoying; Tomaras, Georgia D (2011) Alterations of the B-cell response by HIV-1 replication. Curr HIV/AIDS Rep 8:23-30
McMichael, Andrew J; Borrow, Persephone; Tomaras, Georgia D et al. (2010) The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 10:11-23
Tomaras, Georgia D; Haynes, Barton F (2010) Strategies for eliciting HIV-1 inhibitory antibodies. Curr Opin HIV AIDS 5:421-7
Saunders, Kevin O; Freel, Stephanie A; Overman, R Glenn et al. (2010) Epigenetic regulation of CD8(+) T-lymphocyte mediated suppression of HIV-1 replication. Virology 405:234-42
Miller, Heather B; Saunders, Kevin O; Tomaras, Georgia D et al. (2009) Tat-SF1 is not required for Tat transactivation but does regulate the relative levels of unspliced and spliced HIV-1 RNAs. PLoS One 4:e5710
Tomaras, Georgia D; Haynes, Barton F (2009) HIV-1-specific antibody responses during acute and chronic HIV-1 infection. Curr Opin HIV AIDS 4:373-9